Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.09 trillion and total revenue of $110 billion.
Market Cap
1.09T
Revenue
110B
Profits
-41.42B
PE Ratio
n/a
Profit Margin
-37.66%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.99B | -1.90% | 331,434 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.82B | -1.38% | 365,090 | 14.92B |
| 3 | ARGX | argenx SE | 54.50B | -1.16% | 205,781 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.16B | -1.47% | 449,079 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 31.58B | -1.40% | 992,419 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.49B | -4.11% | 1,504,266 | - |
| 7 | ONC | BeOne Medicines AG | 29.42B | -1.30% | 123,720 | 5.70B |
| 8 | BNTX | BioNTech SE | 21.82B | -0.27% | 526,917 | 3.23B |
| 9 | INCY | Incyte Corporation | 21.28B | 3.21% | 1,613,252 | 5.36B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.69B | -0.98% | 1,725,006 | 8.26M |
| 11 | INSM | Insmed Incorporated | 20.39B | -5.04% | 1,881,253 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 18.43B | -2.70% | 1,522,995 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.29B | -1.69% | 458,111 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.33B | -0.34% | 410,014 | 4.44B |
| 15 | EXEL | Exelixis, Inc. | 13.45B | 1.00% | 881,328 | 2.38B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 0.47% | 1,029,790 | 579.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.19B | -0.43% | 136,101 | 998.25M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.81B | 1.31% | 429,922 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.18B | -1.17% | 618,912 | 1.06B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.11B | -0.73% | 732,967 | 3.24B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.05B | 0.50% | 142,556 | 1.13B |
| 22 | SMMT | Summit Therapeutics Inc. | 10.03B | -9.59% | 3,929,669 | - |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.96B | -3.58% | 624,301 | 622.01M |
| 24 | NUVL | Nuvalent, Inc. | 9.74B | 0.06% | 3,093,519 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.22B | 0.98% | 170,995 | 417.30M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.18B | -1.17% | 549,844 | 105.82M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.54B | 2.62% | 685,872 | 769.10M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.44B | -0.46% | 302,788 | 1.51B |
| 29 | TECH | Bio-Techne Corporation | 8.24B | -3.25% | 1,127,214 | 1.21B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.90B | -4.40% | 870,012 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.43B | -2.21% | 5,223,153 | 140.98M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 6.90B | 1.35% | 427,466 | 74.06M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 6.77B | -3.02% | 169,016 | 7.46M |
| 34 | PCVX | Vaxcyte, Inc. | 6.67B | -1.49% | 292,149 | - |
| 35 | TGTX | TG Therapeutics, Inc. | 6.67B | 8.49% | 3,569,480 | 700.35M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.57B | -0.97% | 547,502 | - |
| 37 | IMVT | Immunovant, Inc. | 6.46B | -0.51% | 531,433 | - |
| 38 | KYMR | Kymera Therapeutics, Inc. | 6.42B | 1.44% | 201,364 | 51.48M |
| 39 | LEGN | Legend Biotech Corporation | 6.38B | 2.57% | 524,500 | 1.14B |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.19B | -2.89% | 337,999 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.21% | 620,444 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.10B | -0.16% | 496,100 | 827.11M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.04B | 0.23% | 502,772 | 217.17M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.81B | -0.23% | 219,548 | 569.61M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.51B | 0.95% | 726,493 | - |
| 46 | BLTE | Belite Bio, Inc | 5.49B | -1.27% | 55,852 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.35B | -2.13% | 756,440 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.02B | -1.65% | 757,120 | 7.50M |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.00B | 2.50% | 128,332 | 274.48M |
| 50 | CAI | Caris Life Sciences, Inc. | 4.88B | 1.77% | 925,158 | 907.29M |
| 51 | CGON | CG Oncology, Inc. | 4.85B | -2.96% | 372,123 | 5.07M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.83B | -2.62% | 624,061 | 4.10M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.44B | -1.80% | 796,679 | 536.20M |
| 54 | CELC | Celcuity Inc. | 4.33B | -4.12% | 1,173,802 | - |
| 55 | TNGX | Tango Therapeutics, Inc. | 4.28B | -6.21% | 5,366,190 | 56.99M |
| 56 | ERAS | Erasca, Inc. | 4.11B | -1.42% | 1,579,228 | - |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 3.98B | -13.84% | 2,897,895 | 1.34M |
| 58 | ORKA | Oruka Therapeutics, Inc. | 3.97B | -1.76% | 447,019 | - |
| 59 | MANE | Veradermics, Incorporated | 3.93B | -1.91% | 105,580 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.02% | 317,707 | 596.96M |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.71B | 0.71% | 223,398 | 18.07M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | -1.79% | 533,143 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.59B | -1.97% | 612,598 | - |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.57B | 44.55% | 2,634,394 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | -1.76% | 239,393 | 22.57M |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.25B | -4.14% | 1,442,662 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.25B | -1.49% | 784,487 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.22B | 0.90% | 27,802 | 803.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.00B | -1.18% | 788,704 | 164.01M |
| 70 | RLAY | Relay Therapeutics, Inc. | 2.97B | -3.26% | 1,538,394 | 10.68M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | 3.69% | 586,645 | 415.62M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.95B | -0.39% | 451,925 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 2.94B | 0.29% | 598,644 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.82B | -5.08% | 757,446 | 236.00M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | 1.72% | 102,449 | 535.08M |
| 76 | ALMS | Alumis Inc. | 2.60B | 2.05% | 495,917 | 8.40M |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.58B | 3.16% | 1,540,431 | - |
| 78 | IRON | Disc Medicine, Inc. | 2.58B | -1.11% | 86,973 | - |
| 79 | KLRA | Kailera Therapeutics, Inc. | 2.53B | -0.41% | 149,765 | - |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.41B | -2.46% | 633,206 | 225.27M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.32B | -0.34% | 135,899 | 865.00K |
| 82 | VERA | Vera Therapeutics, Inc. | 2.30B | 0.57% | 295,451 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | - | 335,695 | 670.00M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.21B | 0.66% | 654,412 | - |
| 85 | PHVS | Pharvaris N.V. | 2.19B | -0.52% | 41,862 | - |
| 86 | IMNM | Immunome, Inc. | 2.05B | -1.36% | 468,735 | 4.02M |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | 0.13% | 307,659 | 298.30M |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | 2.89% | 682,559 | 899.11M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.00B | 0.37% | 443,817 | - |
| 90 | ADMA | ADMA Biologics, Inc. | 1.99B | 5.67% | 2,168,437 | 509.86M |
| 91 | KOD | Kodiak Sciences Inc. | 1.99B | 2.51% | 335,863 | - |
| 92 | ZLAB | Zai Lab Limited | 1.95B | 4.50% | 676,018 | 453.28M |
| 93 | VCEL | Vericel Corporation | 1.93B | 2.30% | 265,826 | 292.09M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -1.40% | 286,050 | - |
| 95 | NKTR | Nektar Therapeutics | 1.90B | 0.09% | 464,976 | 55.63M |
| 96 | LKFT | Lakefront Biotherapeutics NV | 1.87B | 1.08% | 195,768 | 1.20B |
| 97 | MESO | Mesoblast Limited | 1.83B | -2.24% | 40,454 | 65.38M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.82B | -2.13% | 696,907 | 52.04M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.79B | -2.11% | 244,744 | 32.08M |
| 100 | NTLA | Intellia Therapeutics, Inc. | 1.75B | -2.95% | 1,796,244 | 66.09M |
| 101 | VRDN | Viridian Therapeutics, Inc. | 1.75B | -3.03% | 603,689 | 70.92M |
| 102 | IOVA | Iovance Biotherapeutics, Inc. | 1.72B | -0.52% | 4,106,653 | 285.61M |
| 103 | GENB | Generate Biomedicines, Inc. | 1.72B | 1.67% | 212,552 | 30.30M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 1.70B | -0.59% | 138,023 | 20.00M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.70B | 1.53% | 390,889 | 66.05M |
| 106 | INVA | Innoviva, Inc. | 1.70B | 2.09% | 356,924 | 420.69M |
| 107 | BHVN | Biohaven Ltd. | 1.70B | 1.71% | 1,420,584 | - |
| 108 | NBTX | Nanobiotix S.A. | 1.69B | -3.87% | 51,936 | 38.27M |
| 109 | QURE | uniQure N.V. | 1.68B | 0.81% | 507,328 | 18.09M |
| 110 | ZYME | Zymeworks Inc. | 1.68B | -1.29% | 287,526 | 81.26M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | -4.04% | 11,824,996 | 66.41M |
| 112 | NUVB | Nuvation Bio Inc. | 1.63B | -5.17% | 2,443,159 | 143.05M |
| 113 | SRPT | Sarepta Therapeutics, Inc. | 1.61B | -4.03% | 912,402 | 2.18B |
| 114 | AAPG | Ascentage Pharma Group International | 1.61B | 2.58% | 1,271 | 82.08M |
| 115 | FTRE | Fortrea Holdings Inc. | 1.60B | 0.18% | 376,058 | 2.71B |
| 116 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -1.15% | 1,194,003 | 71.78M |
| 117 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | 0.71% | 497,828 | 217.17M |
| 118 | ABCL | AbCellera Biologics Inc. | 1.57B | -2.83% | 2,418,889 | 79.21M |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.53B | -0.65% | 618,539 | 7.47M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.52B | -1.20% | 217,030 | - |
| 121 | SION | Sionna Therapeutics, Inc. | 1.52B | 0.18% | 122,737 | - |
| 122 | ANAB | AnaptysBio, Inc. | 1.51B | 0.26% | 202,972 | 232.39M |
| 123 | CAPR | Capricor Therapeutics, Inc. | 1.48B | -1.96% | 665,160 | 11.13M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.45B | -3.10% | 135,039 | - |
| 125 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | 0.02% | 640,182 | 114.48M |
| 126 | MBX | MBX Biosciences, Inc. | 1.43B | 0.37% | 485,518 | - |
| 127 | IMCR | Immunocore Holdings plc | 1.42B | -1.82% | 68,501 | 412.81M |
| 128 | ATAI | AtaiBeckley Inc. | 1.42B | -0.26% | 1,736,905 | 3.49M |
| 129 | ARDX | Ardelyx, Inc. | 1.42B | 2.32% | 1,327,857 | 427.68M |
| 130 | SEPN | Septerna, Inc. | 1.41B | 0.77% | 53,998 | 72.26M |
| 131 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -1.10% | 91,710 | - |
| 132 | NVAX | Novavax, Inc. | 1.41B | -1.38% | 1,226,658 | 596.34M |
| 133 | GHRS | GH Research PLC | 1.40B | 0.10% | 76,526 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 1.40B | -2.70% | 719,942 | 65.50M |
| 135 | GLUE | Monte Rosa Therapeutics, Inc. | 1.39B | -0.78% | 520,998 | 42.95M |
| 136 | PGEN | Precigen, Inc. | 1.39B | 4.85% | 2,467,105 | 31.60M |
| 137 | URGN | UroGen Pharma Ltd. | 1.36B | -1.03% | 143,516 | 140.49M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.35B | 0.29% | 341,947 | - |
| 139 | SLS | SELLAS Life Sciences Group, Inc. | 1.35B | -5.79% | 4,114,585 | - |
| 140 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | 2.06% | 1,603,089 | 204.73M |
| 141 | INBX | Inhibrx Biosciences, Inc. | 1.31B | -0.06% | 174,790 | 1.30M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.30B | -2.17% | 359,025 | 20.00M |
| 143 | SVRA | Savara Inc. | 1.29B | 2.94% | 876,194 | - |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.28B | -3.83% | 73,859 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.70% | 223,649 | - |
| 146 | AVLN | Avalyn Pharma Inc. | 1.24B | 3.63% | 158,691 | - |
| 147 | IMTX | Immatics N.V. | 1.20B | -3.82% | 108,619 | 43.00M |
| 148 | DMRA | Damora Therapeutics, Inc. | 1.20B | -6.87% | 325,368 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -1.87% | 160,598 | 10.00M |
| 150 | MNKD | MannKind Corporation | 1.12B | 1.54% | 2,051,109 | 360.78M |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | -7.09% | 160,004 | - |
| 152 | WVE | Wave Life Sciences Ltd. | 1.10B | -0.69% | 1,046,725 | 71.80M |
| 153 | ABSI | Absci Corporation | 1.05B | -1.17% | 2,989,225 | 1.84M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.58% | 34,330 | 8.28M |
| 155 | EYPT | EyePoint, Inc. | 975.07M | -1.19% | 392,660 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 955.27M | 1.70% | 708,895 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 943.36M | 0.74% | 95,121 | - |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 939.41M | 0.53% | 638,126 | 98.99M |
| 159 | DBVT | DBV Technologies S.A. | 937.35M | -0.06% | 110,324 | 5.74M |
| 160 | JBIO | Jade Biosciences, Inc. | 910.88M | 0.82% | 623,766 | - |
| 161 | PHAR | Pharming Group N.V. | 894.04M | -0.77% | 1,986 | 369.49M |
| 162 | XNCR | Xencor, Inc. | 880.06M | -0.17% | 239,782 | 97.36M |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 863.87M | -5.36% | 479,652 | - |
| 164 | TBPH | Theravance Biopharma, Inc. | 844.95M | -0.61% | 144,254 | 109.78M |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 843.97M | 1.06% | 613,981 | 69.64M |
| 166 | DRTS | Alpha Tau Medical Ltd. | 843.15M | 1.74% | 247,756 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 834.41M | -2.17% | 134,542 | 79.76M |
| 168 | LBRX | LB Pharmaceuticals Inc | 825.89M | -1.61% | 90,933 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 823.73M | -1.88% | 444,736 | 191.45M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 823.19M | 2.11% | 241,462 | 2.98M |
| 171 | JANX | Janux Therapeutics, Inc. | 808.65M | -2.64% | 416,298 | 13.73M |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 806.40M | -2.62% | 1,125,609 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 802.64M | 2.90% | 353,068 | 204.89M |
| 174 | ANNX | Annexon, Inc. | 795.46M | -6.63% | 885,534 | - |
| 175 | ZVRA | Zevra Therapeutics, Inc. | 795.10M | -1.54% | 1,782,809 | 122.29M |
| 176 | SANA | Sana Biotechnology, Inc. | 794.52M | 1.24% | 1,162,513 | - |
| 177 | KURA | Kura Oncology, Inc. | 782.99M | 0.11% | 572,599 | 71.64M |
| 178 | IVA | Inventiva S.A. | 781.60M | -5.04% | 410,107 | 7.94M |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 753.78M | -6.94% | 1,092,451 | - |
| 180 | EVMN | Evommune, Inc. | 739.10M | 0.15% | 406,973 | 10.00M |
| 181 | OMER | Omeros Corporation | 735.70M | 1.96% | 493,960 | 9.89M |
| 182 | VOR | Vor Biopharma Inc. | 721.21M | 0.23% | 391,969 | - |
| 183 | REPL | Replimune Group, Inc. | 720.03M | -5.63% | 1,167,830 | - |
| 184 | GERN | Geron Corporation | 715.30M | -0.45% | 8,511,991 | 196.12M |
| 185 | AVTX | Avalo Therapeutics, Inc. | 690.71M | 1.86% | 406,146 | 59.00K |
| 186 | CRMD | CorMedix Inc. | 690.38M | 1.73% | 864,952 | 400.05M |
| 187 | ANRO | Alto Neuroscience, Inc. | 690.01M | -6.93% | 148,734 | - |
| 188 | AURA | Aura Biosciences, Inc. | 687.72M | -1.81% | 285,670 | - |
| 189 | DRUG | Bright Minds Biosciences Inc. | 683.54M | -6.00% | 601,862 | - |
| 190 | RLMD | Relmada Therapeutics, Inc. | 681.79M | 3.67% | 866,109 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 675.16M | 2.46% | 344,884 | - |
| 192 | OCS | Oculis Holding AG | 670.91M | 1.18% | 290,245 | 1.40M |
| 193 | SLDB | Solid Biosciences Inc. | 640.91M | -0.91% | 390,760 | - |
| 194 | CTMX | CytomX Therapeutics, Inc. | 640.05M | -1.34% | 788,471 | 35.54M |
| 195 | TENX | Tenax Therapeutics, Inc. | 632.35M | 0.09% | 225,705 | - |
| 196 | SGP | SpyGlass Pharma, Inc. | 617.39M | 1.54% | 19,275 | - |
| 197 | ALLO | Allogene Therapeutics, Inc. | 616.10M | -1.92% | 3,774,193 | 22.00K |
| 198 | CADL | Candel Therapeutics, Inc. | 597.89M | -5.88% | 932,723 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 593.47M | -0.78% | 81,263 | 11.88M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 579.60M | -3.49% | 467,545 | 8.37M |
| 201 | ACHV | Achieve Life Sciences, Inc. | 579.00M | 0.71% | 611,321 | - |
| 202 | IMMX | Immix Biopharma, Inc. | 576.47M | 3.12% | 654,886 | - |
| 203 | RIGL | Rigel Pharmaceuticals, Inc. | 574.86M | 1.14% | 56,930 | 299.77M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 573.57M | -1.38% | 138,169 | - |
| 205 | TRAX | First Tracks Biotherapeutics, Inc. | 565.08M | 1.41% | 123,763 | - |
| 206 | MDXG | MiMedx Group, Inc. | 548.87M | -0.67% | 476,445 | 389.42M |
| 207 | GYRE | Gyre Therapeutics, Inc. | 547.77M | -2.20% | 36,671 | 117.05M |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 529.78M | -1.70% | 575,765 | 151.40M |
| 209 | XOMA | XOMA Royalty Corporation | 524.47M | -0.31% | 58,268 | 48.56M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 521.54M | -3.22% | 19,555 | - |
| 211 | CLYM | Climb Bio, Inc. | 514.94M | -3.19% | 230,743 | - |
| 212 | CABA | Cabaletta Bio, Inc. | 513.62M | -2.17% | 1,580,903 | - |
| 213 | ALT | Altimmune, Inc. | 512.44M | -0.94% | 1,493,241 | 36.00K |
| 214 | AGMB | AgomAb Therapeutics NV | 509.72M | 5.61% | 82,759 | - |
| 215 | PROK | ProKidney Corp. | 505.95M | 0.30% | 118,603 | 889.00K |
| 216 | PRME | Prime Medicine, Inc. | 501.21M | -3.65% | 1,217,030 | 4.03M |
| 217 | VALN | Valneva SE | 499.00M | -1.41% | 6,385 | 180.25M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 468.20M | -1.46% | 288,487 | - |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 461.08M | -4.44% | 246,243 | 88.24M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 460.18M | -3.08% | 58,564 | - |
| 221 | ARVN | Arvinas, Inc. | 454.87M | -2.22% | 296,566 | 89.40M |
| 222 | ASMB | Assembly Biosciences, Inc. | 443.71M | -1.45% | 103,293 | 71.10M |
| 223 | NGNE | Neurogene Inc. | 443.09M | -2.67% | 100,357 | 925.00K |
| 224 | OVID | Ovid Therapeutics Inc. | 439.54M | -2.69% | 789,479 | 7.12M |
| 225 | ANL | Adlai Nortye Ltd. | 435.20M | 0.37% | 23,917 | 5.00M |
| 226 | STRO | Sutro Biopharma, Inc. | 433.32M | 1.40% | 94,018 | 99.61M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 424.71M | -0.61% | 51,555 | - |
| 228 | PRTA | Prothena Corporation plc | 424.06M | -4.37% | 180,029 | 57.94M |
| 229 | FBRX | Forte Biosciences, Inc. | 415.16M | -0.06% | 87,632 | - |
| 230 | CCCC | C4 Therapeutics, Inc. | 406.89M | 2.79% | 1,151,216 | 34.86M |
| 231 | OCGN | Ocugen, Inc. | 406.23M | -3.23% | 3,003,326 | 4.47M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 404.64M | 3.55% | 101,744 | 16.72M |
| 233 | MNPR | Monopar Therapeutics Inc. | 403.27M | -0.71% | 50,080 | - |
| 234 | SGMT | Sagimet Biosciences Inc. | 399.53M | -0.77% | 265,551 | - |
| 235 | RZLT | Rezolute, Inc. | 396.97M | -2.56% | 363,672 | - |
| 236 | IPSC | Century Therapeutics, Inc. | 394.08M | -1.13% | 394,484 | 109.16M |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 390.48M | -1.17% | 70,296 | - |
| 238 | AUTL | Autolus Therapeutics plc | 388.57M | - | 620,250 | 92.62M |
| 239 | EDIT | Editas Medicine, Inc. | 385.19M | -5.28% | 716,109 | 38.69M |
| 240 | VTVT | vTv Therapeutics Inc. | 382.59M | -2.96% | 11,335 | 36.84M |
| 241 | LRMR | Larimar Therapeutics, Inc. | 367.43M | 0.57% | 1,837,423 | - |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 363.52M | -1.23% | 389,644 | 217.78M |
| 243 | XFOR | X4 Pharmaceuticals, Inc. | 361.24M | -0.52% | 209,212 | 9.01M |
| 244 | BNTC | Benitec Biopharma Inc. | 361.06M | -2.78% | 24,989 | - |
| 245 | PBYI | Puma Biotechnology, Inc. | 357.82M | -0.28% | 78,781 | 227.18M |
| 246 | CMPX | Compass Therapeutics, Inc. | 352.97M | -4.85% | 1,624,839 | 850.00K |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 352.12M | 0.92% | 56,676 | - |
| 248 | UPB | Upstream Bio, Inc. | 350.46M | -3.74% | 151,673 | 3.32M |
| 249 | ARTV | Artiva Biotherapeutics, Inc. | 346.43M | -1.93% | 279,221 | 251.00K |
| 250 | OABI | OmniAb, Inc. | 344.31M | -1.04% | 226,541 | 28.94M |
| 251 | VSTM | Verastem, Inc. | 337.43M | 0.52% | 1,072,394 | 49.59M |
| 252 | ZURA | Zura Bio Limited | 337.30M | -3.66% | 443,884 | - |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 332.95M | 0.88% | 47,516 | 69.21M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 330.85M | 1.39% | 40,180 | - |
| 255 | LXEO | Lexeo Therapeutics, Inc. | 329.01M | -1.18% | 181,832 | - |
| 256 | IRD | Opus Genetics, Inc. | 321.51M | -3.19% | 398,716 | 11.98M |
| 257 | RGNX | REGENXBIO Inc. | 320.01M | -2.37% | 311,924 | 87.82M |
| 258 | CNXU | Conexeu Sciences Inc. | 317.90M | -9.76% | 41,192 | - |
| 259 | STTK | Shattuck Labs, Inc. | 314.77M | -3.86% | 946,465 | 1.00M |
| 260 | ABEO | Abeona Therapeutics Inc. | 304.92M | -1.83% | 495,151 | 14.54M |
| 261 | LCTX | Lineage Cell Therapeutics, Inc. | 304.14M | - | 754,465 | 14.78M |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 299.95M | -1.54% | 46,041 | 51.00M |
| 263 | LYEL | Lyell Immunopharma, Inc. | 299.61M | 1.10% | 67,720 | 31.00K |
| 264 | HUMA | Humacyte, Inc. | 296.94M | -3.78% | 3,958,892 | 2.02M |
| 265 | NMRA | Neumora Therapeutics, Inc. | 296.87M | -1.52% | 302,643 | - |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 291.65M | -2.34% | 149,593 | - |
| 267 | IKT | Inhibikase Therapeutics, Inc. | 287.16M | 0.90% | 268,815 | 1.00 |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 286.66M | -1.85% | 66,037 | - |
| 269 | RCKT | Rocket Pharmaceuticals, Inc. | 285.54M | -1.32% | 1,277,641 | - |
| 270 | ARMP | Armata Pharmaceuticals, Inc. | 284.94M | -0.19% | 18,728 | 5.20M |
| 271 | SLN | Silence Therapeutics plc | 284.35M | 0.17% | 62,050 | 839.00K |
| 272 | BCYC | Bicycle Therapeutics plc | 283.78M | -2.52% | 139,844 | 63.50M |
| 273 | IVVD | Invivyd, Inc. | 282.23M | -3.23% | 2,009,255 | 55.87M |
| 274 | PALI | Palisade Bio, Inc. | 281.29M | -0.59% | 780,931 | - |
| 275 | NAGE | Niagen Bioscience, Inc. | 278.54M | -0.57% | 285,837 | 130.42M |
| 276 | NVCT | Nuvectis Pharma, Inc. | 272.02M | 4.64% | 49,189 | - |
| 277 | ELDN | Eledon Pharmaceuticals, Inc. | 269.79M | -1.69% | 368,390 | - |
| 278 | INDP | Indaptus Therapeutics, Inc. | 268.38M | 17.04% | 1,309,228 | - |
| 279 | ELTX | Elicio Therapeutics, Inc. | 261.78M | 0.21% | 163,566 | - |
| 280 | SRZN | Surrozen, Inc. | 255.23M | 2.25% | 19,094 | 7.49M |
| 281 | IMRX | Immuneering Corporation | 254.26M | -2.48% | 637,944 | - |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 252.00M | -1.12% | 229,149 | 26.87M |
| 283 | MGNX | MacroGenics, Inc. | 247.88M | -0.26% | 172,919 | 157.08M |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 241.32M | - | 218,078 | 32.72M |
| 285 | IFRX | InflaRx N.V. | 240.82M | -1.51% | 253,863 | 33.82K |
| 286 | SABS | SAB Biotherapeutics, Inc. | 239.64M | 1.49% | 117,067 | 114.70K |
| 287 | SLGL | Sol-Gel Technologies Ltd. | 237.98M | -4.49% | 10,999 | 18.47M |
| 288 | AVXL | Anavex Life Sciences Corp. | 235.85M | 0.20% | 461,724 | - |
| 289 | CAMP | Camp4 Therapeutics Corporation | 231.78M | 11.31% | 112,387 | 3.93M |
| 290 | FHTX | Foghorn Therapeutics Inc. | 228.98M | 0.78% | 80,515 | 28.22M |
| 291 | CLLS | Cellectis S.A. | 228.33M | 4.01% | 65,557 | 75.11M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 227.55M | -2.98% | 1,075,001 | 80.00M |
| 293 | FATE | Fate Therapeutics, Inc. | 223.79M | 1.05% | 918,004 | 6.32M |
| 294 | TRDA | Entrada Therapeutics, Inc. | 220.89M | -3.77% | 80,543 | 5.74M |
| 295 | NERV | Minerva Neurosciences, Inc. | 219.67M | -0.53% | 25,921 | - |
| 296 | ADAG | Adagene Inc. | 218.77M | -2.62% | 41,663 | 7.67M |
| 297 | YDES | YD Bio Limited | 217.99M | 5.44% | 3,114 | 510.36K |
| 298 | TARA | Protara Therapeutics, Inc. | 217.51M | -2.52% | 290,749 | - |
| 299 | CDXS | Codexis, Inc. | 214.52M | -4.45% | 393,679 | 78.09M |
| 300 | LENZ | LENZ Therapeutics, Inc. | 214.15M | 0.59% | 130,161 | 20.99M |
| 301 | CHRS | Coherus Oncology, Inc. | 212.09M | -3.17% | 299,373 | 46.88M |
| 302 | CNTN | Canton Strategic Holdings, Inc. | 210.81M | 12.69% | 731,326 | - |
| 303 | ACIU | AC Immune SA | 210.80M | -5.97% | 346,270 | 4.62M |
| 304 | UNCY | Unicycive Therapeutics, Inc. | 209.33M | 7.84% | 752,873 | - |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 205.96M | 2.34% | 323,958 | 1.78M |
| 306 | ALXO | ALX Oncology Holdings Inc. | 205.20M | -1.61% | 274,798 | - |
| 307 | VYGR | Voyager Therapeutics, Inc. | 204.83M | -1.17% | 244,569 | 36.49M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 203.00M | -2.73% | 65,540 | 7.15M |
| 309 | KPTI | Karyopharm Therapeutics Inc. | 201.61M | 2.88% | 93,441 | 151.12M |
| 310 | RNA | Atrium Therapeutics, Inc. | 200.82M | -0.17% | 86,770 | 36.68M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.25M | -2.09% | 117,737 | 54.71M |
| 312 | KROS | Keros Therapeutics, Inc. | 198.12M | -0.60% | 64,953 | 33.18M |
| 313 | HELP | Cybin Inc. | 197.14M | 0.51% | 202,704 | - |
| 314 | QTTB | Q32 Bio Inc. | 193.64M | -3.95% | 181,504 | 53.74M |
| 315 | NGEN | NervGen Pharma Corp. | 187.45M | -2.49% | 274,203 | - |
| 316 | CGEN | Compugen Ltd. | 186.80M | -2.23% | 237,555 | 72.66M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.75M | 1.13% | 725,227 | 17.56M |
| 318 | MDWD | MediWound Ltd. | 184.49M | 0.38% | 32,026 | 14.48M |
| 319 | CRBU | Caribou Biosciences, Inc. | 177.53M | -2.72% | 579,742 | 11.20M |
| 320 | NBP | NovaBridge Biosciences | 177.52M | -3.46% | 240,806 | - |
| 321 | NKTX | Nkarta, Inc. | 174.57M | -0.41% | 306,931 | - |
| 322 | EQ | Equillium, Inc. | 173.87M | 1.85% | 121,995 | 4.39M |
| 323 | DTIL | Precision BioSciences, Inc. | 173.65M | -1.90% | 194,241 | 45.07M |
| 324 | OKUR | OnKure Therapeutics, Inc. | 173.09M | 0.82% | 87,614 | - |
| 325 | ALEC | Alector, Inc. | 172.09M | -4.91% | 181,346 | 18.42M |
| 326 | MIST | Milestone Pharmaceuticals Inc. | 170.06M | 3.31% | 643,115 | 1.78M |
| 327 | ENLV | Enlivex Ltd. | 168.71M | 1.05% | 41,463 | - |
| 328 | TTRX | Turn Therapeutics Inc. | 168.30M | 11.77% | 34,694 | - |
| 329 | IPHA | Innate Pharma S.A. | 167.05M | -0.56% | 2,572 | 10.57M |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 165.40M | 4.57% | 310,568 | - |
| 331 | IMUX | Immunic, Inc. | 162.64M | -2.61% | 118,487 | - |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 159.45M | -0.05% | 214,194 | 76.38M |
| 333 | GALT | Galectin Therapeutics Inc. | 157.73M | -0.62% | 189,755 | - |
| 334 | KRRO | Korro Bio, Inc. | 156.05M | -1.10% | 44,687 | 3.84M |
| 335 | TLSA | Tiziana Life Sciences Ltd | 153.88M | -2.46% | 42,362 | - |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 153.22M | -0.55% | 1,067,746 | 225.00K |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 151.02M | 1.10% | 108,922 | 2.00M |
| 338 | PRQR | ProQR Therapeutics N.V. | 148.03M | -4.42% | 332,975 | 15.73M |
| 339 | SPRO | Spero Therapeutics, Inc. | 147.07M | -1.17% | 545,171 | 61.19M |
| 340 | ANTX | AN2 Therapeutics, Inc. | 146.86M | 4.35% | 113,937 | - |
| 341 | MOLN | Molecular Partners AG | 143.54M | -4.12% | 4,491 | 856.30K |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 143.03M | 0.26% | 150,819 | - |
| 343 | ADCT | ADC Therapeutics SA | 141.18M | 0.91% | 1,628,158 | 79.18M |
| 344 | NRXP | NRx Pharmaceuticals, Inc. | 136.46M | -2.58% | 342,686 | 2.29M |
| 345 | CNTX | Context Therapeutics Inc. | 136.44M | -2.30% | 245,204 | - |
| 346 | SPRB | Spruce Biosciences, Inc. | 134.27M | -0.50% | 20,542 | 697.00K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 133.17M | -0.24% | 57,408 | 233.00K |
| 348 | KZIA | Kazia Therapeutics Limited | 132.21M | 1.31% | 30,391 | 1.27M |
| 349 | HURA | TuHURA Biosciences, Inc. | 131.19M | 1.98% | 241,263 | - |
| 350 | AGEN | Agenus Inc. | 130.64M | 1.13% | 423,873 | 123.87M |
| 351 | MENS | Jyong Biotech Ltd. | 129.91M | -3.31% | 148,981 | - |
| 352 | ACOG | Alpha Cognition Inc. | 129.12M | -1.17% | 22,458 | 10.83M |
| 353 | GNLX | Genelux Corporation | 126.79M | -4.19% | 90,196 | 8.00K |
| 354 | ALPS | Alps Group Inc | 117.23M | -0.07% | 1,905 | 3.74M |
| 355 | GUTS | Fractyl Health, Inc. | 113.81M | 8.02% | 614,714 | 3.00K |
| 356 | NTHI | NeOnc Technologies Holdings, Inc. | 112.66M | 0.68% | 10,460 | 39.99K |
| 357 | VRCA | Verrica Pharmaceuticals Inc. | 108.91M | 3.59% | 22,909 | 37.16M |
| 358 | PLYX | Polaryx Therapeutics, Inc. | 108.89M | 0.88% | 27,208 | - |
| 359 | ENGN | enGene Therapeutics Inc. | 108.19M | -3.29% | 586,159 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 107.73M | -1.05% | 760,961 | 70.00M |
| 361 | PYXS | Pyxis Oncology, Inc. | 107.70M | - | 68,407 | 13.86M |
| 362 | COYA | Coya Therapeutics, Inc. | 105.56M | 0.45% | 96,732 | 7.94M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 103.20M | 0.43% | 300,475 | - |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 102.24M | -1.45% | 443,021 | - |
| 365 | OTLK | Outlook Therapeutics, Inc. | 101.53M | 19.20% | 10,818,456 | 333.14K |
| 366 | CRDF | Cardiff Oncology, Inc. | 100.85M | -3.59% | 549,364 | 525.00K |
| 367 | CUE | Cue Biopharma, Inc. | 100.09M | 1.00% | 13,786 | 32.73M |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 98.50M | 1.35% | 10,283 | - |
| 369 | VANI | Vivani Medical, Inc. | 98.28M | -0.03% | 14,761 | - |
| 370 | PEPG | PepGen Inc. | 98.22M | 2.90% | 263,427 | - |
| 371 | SEER | Seer, Inc. | 94.84M | 2.07% | 38,680 | 15.17M |
| 372 | PTHS | Pelthos Therapeutics Inc. | 94.19M | 0.74% | 6,866 | 27.70M |
| 373 | ONCY | Oncolytics Biotech Inc. | 94.06M | - | 1,211,725 | - |
| 374 | FBIO | Fortress Biotech, Inc. | 93.68M | -3.75% | 174,232 | 66.16M |
| 375 | CBUS | Cibus, Inc. | 91.54M | -2.44% | 165,663 | 3.64M |
| 376 | PMN | ProMIS Neurosciences, Inc. | 90.57M | 3.64% | 14,417 | - |
| 377 | ICCC | ImmuCell Corporation | 90.38M | 2.25% | 20,831 | 29.93M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 90.13M | - | 411,268 | 65.34K |
| 379 | PYPD | PolyPid Ltd. | 87.05M | -0.66% | 29,447 | - |
| 380 | ATRA | Atara Biotherapeutics, Inc. | 85.80M | 3.17% | 36,009 | 23.14M |
| 381 | RNTX | Rein Therapeutics Inc. | 85.75M | 0.14% | 157,715 | - |
| 382 | RLYB | Rallybio Corporation | 84.85M | 0.82% | 7,499 | 858.00K |
| 383 | HYFT | MindWalk Holdings Corp. | 84.43M | 2.41% | 776,898 | 20.70M |
| 384 | BMEA | Biomea Fusion, Inc. | 83.51M | 1.76% | 483,149 | - |
| 385 | CSBR | Champions Oncology, Inc. | 83.32M | 3.63% | 1,272 | 57.95M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 80.87M | 2.31% | 780,479 | - |
| 387 | LIXT | Lixte Biotechnology Holdings, Inc. | 80.86M | 1.31% | 104,628 | - |
| 388 | LONA | LeonaBio, Inc. | 79.75M | 0.35% | 6,676 | - |
| 389 | ANIX | Anixa Biosciences, Inc. | 79.46M | -1.25% | 62,728 | - |
| 390 | AARD | Aardvark Therapeutics, Inc. | 78.76M | 0.84% | 46,700 | - |
| 391 | NRXS | NeurAxis, Inc. | 78.24M | - | 35,305 | 4.28M |
| 392 | OKYO | OKYO Pharma Limited | 78.19M | -3.25% | 48,018 | - |
| 393 | RANI | Rani Therapeutics Holdings, Inc. | 78.02M | -3.64% | 366,575 | 3.17M |
| 394 | HRTX | Heron Therapeutics, Inc. | 77.60M | 1.26% | 2,293,373 | 150.71M |
| 395 | ACET | Adicet Bio, Inc. | 77.39M | 0.82% | 17,750 | - |
| 396 | OSTX | OS Therapies Incorporated | 76.38M | -1.44% | 125,158 | - |
| 397 | ANVS | Annovis Bio, Inc. | 73.60M | -2.26% | 725,629 | - |
| 398 | PLRX | Pliant Therapeutics, Inc. | 72.45M | -1.68% | 159,975 | - |
| 399 | XBIT | XBiotech Inc. | 72.10M | -0.21% | 5,366 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 71.19M | -4.43% | 17,851 | 4.43M |
| 401 | BYSI | BeyondSpring Inc. | 70.73M | - | 6,005 | 1.88M |
| 402 | GANX | Gain Therapeutics, Inc. | 70.59M | 0.30% | 233,131 | - |
| 403 | EXOZ | eXoZymes, Inc. | 68.51M | 3.59% | 4,980 | -700.00 |
| 404 | CING | Cingulate Inc. | 65.85M | 6.67% | 200,895 | - |
| 405 | FLNA | Filana Therapeutics, Inc. | 65.46M | -4.58% | 133,914 | - |
| 406 | IBO | Impact BioMedical Inc. | 63.59M | 2.29% | 84,218 | 39.00K |
| 407 | IMA | ImageneBio, Inc. | 63.16M | 0.90% | 7,010 | 800.00K |
| 408 | MNOV | MediciNova, Inc. | 63.00M | 0.79% | 11,729 | 596.64K |
| 409 | TCRX | TScan Therapeutics, Inc. | 62.39M | -1.12% | 204,033 | 9.14M |
| 410 | PDSB | PDS Biotechnology Corporation | 61.12M | 6.31% | 663,096 | - |
| 411 | IBIO | iBio, Inc. | 60.72M | -1.18% | 234,869 | 300.00K |
| 412 | INKT | MiNK Therapeutics, Inc. | 59.58M | 1.18% | 19,249 | - |
| 413 | MCRB | Seres Therapeutics, Inc. | 59.36M | -3.16% | 32,075 | 1.15M |
| 414 | ACRV | Acrivon Therapeutics, Inc. | 59.28M | -2.46% | 145,167 | - |
| 415 | ENTX | Entera Bio Ltd. | 58.82M | -2.05% | 11,261 | 42.00K |
| 416 | PMVP | PMV Pharmaceuticals, Inc. | 56.53M | 0.95% | 77,346 | - |
| 417 | TIL | Instil Bio, Inc. | 54.05M | -0.62% | 2,733 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 49.77M | 2.35% | 3,464 | 10.86M |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 49.10M | 1.38% | 37,608 | - |
| 420 | ESLA | Estrella Immunopharma, Inc. | 49.06M | -0.87% | 25,909 | - |
| 421 | LTRN | Lantern Pharma Inc. | 48.93M | 0.66% | 84,765 | - |
| 422 | VERU | Veru Inc. | 48.87M | -1.77% | 601,511 | 16.89M |
| 423 | IMMP | Immutep Limited | 47.71M | -3.82% | 260,293 | 5.28M |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 47.44M | 2.44% | 42,080 | 22.33M |
| 425 | MREO | Mereo BioPharma Group plc | 47.24M | -3.19% | 1,764,762 | 500.00K |
| 426 | XLO | Xilio Therapeutics, Inc. | 46.64M | -1.33% | 7,182 | 53.48M |
| 427 | ACTU | Actuate Therapeutics, Inc. | 46.18M | -3.98% | 95,558 | - |
| 428 | EDSA | Edesa Biotech, Inc. | 45.36M | 3.33% | 82,761 | - |
| 429 | TVGN | Tevogen Bio Holdings Inc. | 45.20M | 0.42% | 37,777 | - |
| 430 | ATYR | aTyr Pharma, Inc. | 45.01M | 0.75% | 558,738 | 190.00K |
| 431 | KALA | KALA BIO, Inc. | 44.34M | 1.49% | 49,746 | - |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 43.15M | 3.72% | 39,036 | - |
| 433 | NTRB | Nutriband Inc. | 42.67M | -0.57% | 5,993 | 2.04M |
| 434 | GRDX | GridAI Technologies Corp. | 38.39M | -9.42% | 29,041 | - |
| 435 | RNXT | RenovoRx, Inc. | 38.36M | -1.09% | 125,291 | 1.49M |
| 436 | ATOS | Atossa Therapeutics, Inc. | 37.98M | - | 18,498 | - |
| 437 | PSTV | Plus Therapeutics, Inc. | 37.41M | -1.18% | 80,439 | 5.18M |
| 438 | HYPD | Hyperion DeFi, Inc. | 35.94M | -2.32% | 185,469 | 1.04M |
| 439 | GRCE | Grace Therapeutics, Inc. | 35.44M | -1.72% | 89,822 | - |
| 440 | GOSS | Gossamer Bio, Inc. | 35.37M | -5.81% | 17,493,992 | 55.54M |
| 441 | GNTA | Genenta Science S.p.A. | 34.21M | -9.38% | 366,139 | - |
| 442 | ELOX | Eloxx Pharmaceuticals, Inc. | 33.44M | -11.63% | 53,268 | - |
| 443 | ABVC | ABVC BioPharma, Inc. | 33.10M | -0.76% | 17,793 | 797.92K |
| 444 | LSTA | Lisata Therapeutics, Inc. | 33.06M | 5.78% | 785,809 | 170.00K |
| 445 | INMB | INmune Bio Inc. | 32.83M | 1.23% | 118,103 | 50.00K |
| 446 | ATNM | Actinium Pharmaceuticals, Inc. | 31.96M | 1.49% | 77,043 | 90.00K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 31.81M | - | 18,626 | 4.71M |
| 448 | EVAX | Evaxion A/S | 31.44M | 3.85% | 13,629 | 7.53M |
| 449 | NNVC | NanoViricides, Inc. | 31.21M | -2.14% | 249,245 | - |
| 450 | APLM | Apollomics, Inc. | 31.16M | -0.77% | 3,693 | 8.84M |
| 451 | BOLD | Boundless Bio, Inc. | 31.16M | -0.71% | 33,602 | - |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 30.50M | 8.12% | 157,577 | 38.00K |
| 453 | DARE | Daré Bioscience, Inc. | 29.51M | 2.60% | 79,438 | 1.16M |
| 454 | IGC | IGC Pharma, Inc. | 27.93M | -0.81% | 150,719 | 1.11M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 27.75M | -6.17% | 20,385 | 14.97M |
| 456 | KYNB | Kyntra Bio, Inc. | 27.38M | 1.10% | 2,392 | 7.44M |
| 457 | SKYE | Skye Bioscience, Inc. | 26.56M | 0.71% | 84,218 | - |
| 458 | BCTX | BriaCell Therapeutics Corp. | 26.37M | -0.98% | 32,869 | - |
| 459 | DYAI | Dyadic International, Inc. | 26.27M | 6.75% | 108,511 | 3.81M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 26.16M | -2.63% | 72,895 | - |
| 461 | SER | Serina Therapeutics, Inc. | 25.48M | -3.39% | 40,261 | 130.00K |
| 462 | LITS | Lite Strategy, Inc. | 25.47M | -1.02% | 82,245 | - |
| 463 | TVRD | Tvardi Therapeutics, Inc. | 25.24M | -3.24% | 29,187 | - |
| 464 | PTN | Palatin Technologies, Inc. | 24.91M | -4.93% | 5,246 | 12.88M |
| 465 | PLUR | Pluri Inc. | 24.82M | -3.36% | 4,326 | 1.08M |
| 466 | ALLR | Allarity Therapeutics, Inc. | 24.74M | -0.62% | 98,265 | 345.00K |
| 467 | QNTM | Quantum BioPharma Ltd. | 24.53M | 3.57% | 91,778 | - |
| 468 | LGVN | Longeveron Inc. | 24.14M | 0.29% | 85,337 | 1.22M |
| 469 | MRKR | Marker Therapeutics, Inc. | 23.84M | 1.42% | 18,847 | 3.55M |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 23.35M | -7.30% | 50,630 | -13.27K |
| 471 | VYNE | VYNE Therapeutics Inc. | 22.31M | -0.18% | 13,873 | 454.00K |
| 472 | PLRZ | Polyrizon Ltd. | 22.09M | 3.06% | 6,088 | - |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 21.41M | 0.46% | 316,684 | 789.00K |
| 474 | CELU | Celularity Inc. | 20.70M | 3.85% | 45,985 | 26.55M |
| 475 | CRVO | CervoMed Inc. | 20.46M | -23.53% | 857,634 | 2.09M |
| 476 | TRAW | Traws Pharma, Inc. | 19.24M | -3.05% | 346,048 | 2.73M |
| 477 | KTTA | Pasithea Therapeutics Corp. | 19.03M | -1.81% | 99,970 | - |
| 478 | AEON | AEON Biopharma, Inc. | 18.68M | -0.91% | 51,911 | - |
| 479 | CLRB | Cellectar Biosciences, Inc. | 18.62M | -1.27% | 49,713 | - |
| 480 | TPST | Tempest Therapeutics, Inc. | 18.50M | 1.57% | 17,921 | - |
| 481 | CVM | CEL-SCI Corporation | 17.97M | -4.62% | 207,489 | - |
| 482 | XCUR | Exicure, Inc. | 17.85M | -1.75% | 8,113 | 500.00K |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 17.66M | -2.94% | 108,207 | 1.14M |
| 484 | NCEL | NewcelX Ltd. | 17.23M | 0.97% | 23,317 | - |
| 485 | AKTX | Akari Therapeutics, Plc | 17.15M | -0.13% | 20,790 | - |
| 486 | LEXX | Lexaria Bioscience Corp. | 17.04M | 2.92% | 94,343 | 368.00K |
| 487 | CRIS | Curis, Inc. | 16.95M | -5.17% | 88,405 | 7.06M |
| 488 | PASG | Passage Bio, Inc. | 16.82M | -5.83% | 28,752 | - |
| 489 | LPCN | Lipocine Inc. | 16.29M | -0.98% | 49,107 | 2.00M |
| 490 | QNCX | Quince Therapeutics, Inc. | 15.58M | -1.48% | 183,728 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.37M | 3.79% | 8,013 | 152.72K |
| 492 | SNSE | Sensei Biotherapeutics, Inc. | 15.32M | -9.58% | 10,817 | - |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 15.21M | -0.32% | 132,306 | 5.61M |
| 494 | GTBP | GT Biopharma, Inc. | 15.21M | 0.91% | 302,645 | - |
| 495 | CALC | CalciMedica, Inc. | 14.98M | 4.58% | 128,291 | - |
| 496 | MLEC | Moolec Science SA | 14.60M | -2.09% | 6,004 | 7.83M |
| 497 | OSRH | OSR Holdings, Inc. | 14.48M | 2.48% | 349,481 | 2.63M |
| 498 | BLRX | BioLineRx Ltd. | 14.19M | 1.56% | 2,960 | 1.40M |
| 499 | COCP | Cocrystal Pharma, Inc. | 13.86M | -1.47% | 36,824 | 225.00K |
| 500 | INAB | IN8bio, Inc. | 13.84M | -3.10% | 13,701 | - |